|
COPYRIGHT 2005 International Medical News Group
VIENNA -- Despite unsightly local crusting, the topical imiquimod is effective, noninvasive, and a "very attractive drug," for the treatment of basal cell carcinoma, Reinhard Dummer, M.D., said at the annual meeting of the European Society for Dermatological Research.
But in a socially conservative community, such as the international banking center of Zurich, treatment can present certain challenges. "I have many patients who are bankers. They would never go to the office while using this drug because of the crusting and inflammation," Dr. Dummer said.
As a result, many...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
